173 related articles for article (PubMed ID: 21465479)
41. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
42. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
[TBL] [Abstract][Full Text] [Related]
43. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
44. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
To KK; Yu L; Liu S; Fu J; Cho CH
Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
[TBL] [Abstract][Full Text] [Related]
45. Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2.
Zhang JT
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):531-41. PubMed ID: 17767037
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK
Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123
[TBL] [Abstract][Full Text] [Related]
47. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
[TBL] [Abstract][Full Text] [Related]
48. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
[TBL] [Abstract][Full Text] [Related]
49. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
Candeil L; Gourdier I; Peyron D; Vezzio N; Copois V; Bibeau F; Orsetti B; Scheffer GL; Ychou M; Khan QA; Pommier Y; Pau B; Martineau P; Del Rio M
Int J Cancer; 2004 May; 109(6):848-54. PubMed ID: 15027118
[TBL] [Abstract][Full Text] [Related]
50. [Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].
Qu HB; Fan YM; Han ML; Luo HJ; Xie J; Liu H; Liu H; Wu CY; Tang WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):171-6. PubMed ID: 23643006
[TBL] [Abstract][Full Text] [Related]
51. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
52. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
53. Functional expression and characterization in Xenopus laevis oocytes of the ABCG2 transporter derived from A549 human lung adenocarcinoma cells.
Lee DG; Cho HJ; Yi H; Cho SM; Jo K; Park JA; Lee BH; Hwang SH; Jeong SM; Nah SY; Shin HC
Oncol Rep; 2012 Feb; 27(2):499-503. PubMed ID: 21971989
[TBL] [Abstract][Full Text] [Related]
54. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
[TBL] [Abstract][Full Text] [Related]
55. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.
Sun R; Jiang B; Qi H; Zhang X; Yang J; Duan J; Li Y; Li G
Cell Death Dis; 2015 Nov; 6(11):e1990. PubMed ID: 26583330
[TBL] [Abstract][Full Text] [Related]
56. ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.
Abbott BL
Clin Adv Hematol Oncol; 2006 Jan; 4(1):63-72. PubMed ID: 16562373
[TBL] [Abstract][Full Text] [Related]
57. [Expression and significance of ABCG2 in human malignant glioma].
Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
[TBL] [Abstract][Full Text] [Related]
58. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells.
Kim JB; Ko E; Han W; Shin I; Park SY; Noh DY
Planta Med; 2008 Nov; 74(14):1693-700. PubMed ID: 18951337
[TBL] [Abstract][Full Text] [Related]
59. [Transcriptional regulation of breast cancer resistance protein].
Wu XG; Peng SB; Huang Q
Yi Chuan; 2012 Dec; 34(12):1529-36. PubMed ID: 23262099
[TBL] [Abstract][Full Text] [Related]
60. Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling.
Wang J; Xin B; Wang H; He X; Wei W; Zhang T; Shen X
Exp Cell Res; 2016 Aug; 346(1):74-84. PubMed ID: 27264047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
